地点：加拿大不列颠温哥华
时间：2019年7月24-26日
关于会议*
在过去的16年中，精准医疗暨离子通道论坛（PMICR）已发展成为药物开发，基因组学和离子通道研究的重要会议之一。第17届PMICR将继续保持这种优秀的传统，致力于提供探索世界各地尖端技术和创新研究的平台。这种多样化的活动使学术界和行业研究人员能够分享知识，交换意见并建立富有成效的伙伴关系。会议旨在最大限度地提供愉悦和轻松的交流氛围。
会议议题*
*议题有可能发生变化，以实际公布为准。
Precision Medicine Sessions
- Key Methodologies in Precision Medicine for Drug Discovery
- Next-Generation Sequencing – Applications and Advancement of Genomic Medicine
- Immunotherapy for Personalized Medicine
- Cancer Care, Diagnosis & Treatment
- Microarray and Microfluidic Technologies: Potential in Medicine & Diagnostics
- Latest Applications of Liquid Biopsy Research
- Stem Cells and Drug Development
Ion Channel Sessions
- Key Methodologies in Ion Channel Research for Drug Discovery
- Cardiac Safety, CiPA and its impact on drug discovery
- Role of Ion Channels in Cancer Treatment
- Ion Channels as Pain Targets
- Ion Channels as Disease Targets: Alzheimer and Neurodegenerative disease, ALS, Cystic Fibrosis, Epilepsy, Infectious disease
- Emerging Areas of Ion Transporter Research
- Ion Channels & Immune System
部分与会嘉宾*
- Aaron McMurtray, M.D., Ph.D.- Associate Clinical Professor of Neurology, David Geffen School of Medicine at University of California; Los Angeles
- Andrea Ghetti, Ph.D.- Chief Executive Officer at AnaBios Corporation
- Annarosa Arcangeli, Ph.D.- Professor in the Department of Experimental and Clinical Medicine at University of Florence
- Chris Mathes, Ph.D.- Chief Commercial Officer at AnaBios Corporation
- Christine Beeton, Ph.D.- Graduate Program Director of Biomedical Sciences and Associate Professor in the Department of Molecular Physiology and Biophysics at Baylor College of Medicine
- David Hackos, Ph.D.- Senior Scientist at Genentech, Inc.
- David Smith, Ph.D.- Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic
- Elena Dragicevic, Ph.D. – Alliance Manager at Nanion Technologies GmbH
- Eric Nisenbaum, Ph.D.- Senior Director CNS Research at Alkermes
- Fernanda Laezza, M.D., Ph.D.- Graduate Program Director and Associate Professor in the Department of Pharmacology and Toxicology at the University of Texas Medical Branch
- Filip Van Petegem, Ph.D.- Professor in the Department of Biochemistry and Molecular Biology at University of British Columbia
- Georg Terstappen, Ph.D.- Chief Scientific Officer at OxStem
- Hailong An, Ph.D.- Deputy Director and Professor in the Institute of Biophysics at Hebei University of Technology
- Isabelle Deschenes, Ph.D.- Professor of Medicine, Physiology & Biophysics and Biomedical Engineering at Case Western Reserve University
- James L. Ellis, Ph.D.- Chief Scientific Officer at Nocion Therapeutics
- Jinwei Zhang, Ph.D.- Principal Investigator in the Laboratory of Molecular Biology at National Institute of Health
- Jonathan Davila, Ph.D.- Chief Executive Officer and Co-Founder at Neucyte
- Jonas Korlach, Ph.D.- Chief Scientific Officer at Pacific Biosciences
- JP Johnson, Ph.D.- Vice President, Biology at Xenon Pharmaceuticals Inc.
- Khaled Barakat, Ph.D.- Assistant Professor in the Faculty of Pharmacy and Pharmaceutical Sciences at University of Alberta
- Kevin Foskett, Ph.D.- Isaac Ott Professor of Physiology at University of Pennsylvania
- Laura Hilton, Ph.D.- Postdoctoral Fellow at Simon Fraser University
- Marc Pourrier, Ph.D.- Vice President, Operations at IonsGate
- Marc Rogers, Ph.D.- Chief Scientific Officer at Metrion Biosciences
- Marzia Martina, Ph.D.- Team Leader, Electrophysiology in Human Health Therapeutics at National Research Council of Canada
- Merritt Maduke, Ph.D.- Associate Professor of Molecular and Cellular Physiology at Stanford University
- Michelina Iacovino, Ph.D.- Assistant Professor in the Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles
- Mohamed Chahine, Ph.D.- Professor in the Department of Medicine at Laval University and CERVO Brain Research Centre
- Najah Abi-Gerges, Ph.D.- Vice President, Research & Development at AnaBios Corporation
- Oleg Yerstein, Ph.D.- Postdoctoral Fellow in the Department of Neurology, David Geffen School of Medicine at University of California; Los Angeles
- Owen McManus, Ph.D.- Chief Technology Officer at Q-State Biosciences
- Paul C.H. Li, Ph.D.- Professor in the Department of Chemistry at Simon Fraser University
- Samir Hanash, Ph.D.- Director, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center
- Stefan Feske, M.D., Ph.D.- Jeffrey Bergstein Professor of Medicine and Director of the Ion Channel & Immunity Program at New York University School of Medicine
- Terry Snutch, Ph.D.- Professor and the Canada Research Chair in Biotechnology and Genomics- Neurobiology at University of British Columbia
- Tzyh-Chang Hwang, M.D., Ph.D.- Professor in the Department of Medical Pharmacology and Physiology at University of Missouri
- Wayne Giles, Ph.D.- Professor in the Faculty of Kinesiology at University of Calgary
- Xiaoliang Wang, Ph.D.- Director of the Institute of Pharmacology at Chinese Academic of Medical Sciences
- Yan Xu, Ph.D.- Peter Winter Professor of Anesthesiology & Perioperative Medicine at University of Pittsburgh
- Yingji Li, Ph.D.- Vice President and Founder of ICE Bioscience
- Yuji Imaizumi, Ph.D.- Professor in the Department of Molecular and Cellular Pharmacology at Nagoya City University
- Zhiyuan Li, Ph.D.- Principal Investigator at Guangzhou Institutes of Biomedicine and Health
会议地点及酒店信息**
Sheraton Vancouver Wall Center
1088 Burrard Street, Vancouver
British Columbia, Canada, V6Z 2R9
Tel: +1 (604) 331-1000
https://www.marriott.com/hotels/travel/yvrws-sheraton-vancouver-wall-centre/
We have arranged discounted pricing at this hotel. You can book accommodation online or by calling their toll free number +1-888-236-2427 and requesting the Aurora Biomed Conference rate.
Last Day to Book at discounted rate: Tuesday, July 2, 2019
Room pricing: $319 CAD/ night
往期嘉宾*
- Craig January, MD, PhD – Professor at the School of Medicine and Public Health, at the University of Wisconsin
- William Catterall, PhD – Professor and Chair of University of Washington Department of Pharmacology
- Arthur Brown, PhD – CEO of MemChan; former founder & CEO of ChanTest
- Yuko Sekino, PhD – Director of Pharmacology National Institute of Health Sciences, Japan
- Edward Stevens, PhD – Head of Electrophysiology at Pfizer, Cambridge, UK
- Dennis Lo, MD, PhD – Associate Dean, Faculty of Medicine at CUHK, Foreign Associate US Academy of Sciences
- George Chandy, MD, PhD – Professor at NTU SG and UC Irvine
- Kurt Stoeckli – President & CSO at Glenmark Pharmaceuticals, Switzerland
- Hailin Zhang, MD, PhD – Vice President of Hebei Medical University
- Richard Olsen, PhD – Distinguished Professor of Neuroscience at the David Geffen School of Medicine at UCLA
- Yuklam Lo – Secretariat, and Honorary Chairman, Hong Kong Biotechlogy Organization
- An Hailong – Hebei University of Technology; Professor
- Dan Minor, PhD – Professor, Biochemistry and Biophysics, Cellular and Molecular Pharmacology, University of California
- Steve Goldstein, MD, PhD – Director at the Institute of Pediatric Sciences, University of Chicago
- John Dunlop, PhD – VP, Neuroscience Research at Amgen, Professor of Neuroscience, University of St Andrews
- Laszlo Urban, MD, PhD – Executive Director at Novartis
- Jean-Pierre Valentin, PhD – Senior Director, Head of Investigative Toxicology at UCB
赞助商*
合作媒体*
